Özge Çetinarslan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Özge Çetinarslan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alev Arat Özkan
Cardiology Institute, Instanbul University, 34093 Instanbul, Turkey
2 shared publications Fatih Mehmet Uçar
Department of Cardiology, Demiroğlu Science University, İstanbul Florence Nightingale Hospital, İstanbul, Türkiye
2 shared publications- Umit Yasar Sinan
Department of Cardiology, Istanbul University-Cerrahpasa, Institute of Cardiology, Istanbul, Turkiye
2 shared publications - Ahmet Atasever
Liver Transplantation Center, TC Demiroğlu Science University, Istanbul Florence Nightingale Hospital, Istanbul, Turkey
1 shared publication Cansu Akdeniz
1 shared publicationDidem Dikerdem
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 12 (1) , 44-47
Beyond hypertrophic cardiomyopathy: Cardiac amyloidosis as the first manifestation of myeloma
Cardiac amyloidosis is a frequently overlooked cause of heart failure with preserved ejection fraction, often mimicking hypertrophic cardiomyopathy (HCM). Its clinical presentation may include nonspecific findings such as pleural effusions and dyspnea, contributing to diagnostic delays. We report a 51-year-old woman previously diagnosed with HCM, who presented with progressive dyspnea and recurrent pleural effusions with a near-preserved left ventricular ejection fraction (~50%). This case emphasizes the importance of considering infiltrative cardiomyopathies in the differential diagnosis of unexplained hypertrophy and highlights the role of multimodal imaging in unveiling systemic diseases with cardiac involvement.
- 30 April 2026
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 12 (1) , 44-47
Open AccessBeyond hypertrophic cardiomyopathy: Cardiac amyloidosis as the first manifestation of myeloma
Cardiac amyloidosis is a frequently overlooked cause of heart failure with preserved ejection fraction, often mimicking hypertrophic cardiomyopathy (HCM). Its clinical presentation may include nonspecific findings such as pleural effusions and dyspnea, contributing to diagnostic delays. We report a 51-year-old woman previously diagnosed with HCM, who presented with progressive dyspnea and recurrent pleural effusions with a near-preserved left ventricular ejection fraction (~50%). This case emphasizes the importance of considering infiltrative cardiomyopathies in the differential diagnosis of unexplained hypertrophy and highlights the role of multimodal imaging in unveiling systemic diseases with cardiac involvement.
- 29 January 2026
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (3) , 150-153
Tachycardia-induced cardiomyopathy reversal and spontaneous closure of iatrogenic atrial septal defect following AF ablation: A case report
Atrial fibrillation (AF) is associated with significant morbidity and mortality, particularly due to its relationship with left ventricular dysfunction. This case report describes a 73-year-old female patient with AF and heart failure with reduced ejection fraction, who demonstrated significant left ventricular function recovery following cryoballoon ablation. This case report also underscores the vital role of catheter ablation in managing AF-induced heart failure (HF) and illustrates the benign course of small iatrogenic atrial septal defects post-procedure. By recognizing tachycardia-induced cardiomyopathy, clinicians can prioritize appropriate interventions for patients with new-onset HF and AF, leading to substantial improvements in cardiac function and overall outcomes.
- 29 January 2026
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (3) , 150-153
Tachycardia-induced cardiomyopathy reversal and spontaneous closure of iatrogenic atrial septal defect following AF ablation: A case report
Atrial fibrillation (AF) is associated with significant morbidity and mortality, particularly due to its relationship with left ventricular dysfunction. This case report describes a 73-year-old female patient with AF and heart failure with reduced ejection fraction, who demonstrated significant left ventricular function recovery following cryoballoon ablation. This case report also underscores the vital role of catheter ablation in managing AF-induced heart failure (HF) and illustrates the benign course of small iatrogenic atrial septal defects post-procedure. By recognizing tachycardia-induced cardiomyopathy, clinicians can prioritize appropriate interventions for patients with new-onset HF and AF, leading to substantial improvements in cardiac function and overall outcomes.
- Open Access
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 379-387
A Closer Look at Magnesium Supplementation in Normomagnesemic Patients: Does Formulation Make a Difference?
Objectives: Magnesium (Mg) influences vascular tone, cardiac conduction, and autonomic balance. Its use as an oral supplement has increased rapidly in recent years. However, comparative data on oral formulations are limited, particularly in individuals with normal serum Mg levels. This study aimed to compare the haemodynamic, electrophysiologic, and autonomic effects of Mg oxide with an organic combination (malate + bisglycinate + citrate) in normomagnesemic adults. Methods: We conducted a single‑centre, ambispective cohort of 181 adults assigned to Mg‑oxide (n=62), combination (n=61), or control (no supplement; n=58). All participants had paired evaluations after ≥1 month including ECG, 24‑hour Holter, and ambulatory blood pressure monitoring (ABPM). Outcomes were 24‑hour BP and HR, ECG intervals, arrhythmic burden, and time‑ and frequency‑domain HRV. Adjusted analyses used inverse‑probability weighting. Key exclusions were recent medication changes, cardiac implantable devices, chronic kidney disease, new cardiovascular disease, active infection, and shifts in physical activity. Results: Serum Mg increased in both supplementation arms; serum creatinine fell modestly, with no between‑group differences in change. Compared with combination and control, Mg‑oxide achieved greater reductions in 24‑hour systolic BP (mean Δ −4.2 mmHg; p=0.003) and 24‑hour diastolic BP (Δ −3.5 mmHg; p=0.003), plus a decrease in nighttime diastolic BP (Δ −4.4 mmHg; p=0.014). HR also declined with Mg‑oxide overnight (Δ −2.9 bpm; p=0.049) and over 24 hours (Δ −2.9 bpm; p=0.007), whereas changes with the combination or control were negligible. Time‑domain HRV improved with Mg‑oxide (RMSSD +22.2 ms, p=0.000; pNN50 +2.9%, p=0.006; NN50 +4.1×10³, p=0.032), with between‑group differences favouring Mg‑oxide for RMSSD, pNN50, and NN50 (all p
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 379-387
Open AccessA Closer Look at Magnesium Supplementation in Normomagnesemic Patients: Does Formulation Make a Difference?
Objectives: Magnesium (Mg) influences vascular tone, cardiac conduction, and autonomic balance. Its use as an oral supplement has increased rapidly in recent years. However, comparative data on oral formulations are limited, particularly in individuals with normal serum Mg levels. This study aimed to compare the haemodynamic, electrophysiologic, and autonomic effects of Mg oxide with an organic combination (malate + bisglycinate + citrate) in normomagnesemic adults. Methods: We conducted a single‑centre, ambispective cohort of 181 adults assigned to Mg‑oxide (n=62), combination (n=61), or control (no supplement; n=58). All participants had paired evaluations after ≥1 month including ECG, 24‑hour Holter, and ambulatory blood pressure monitoring (ABPM). Outcomes were 24‑hour BP and HR, ECG intervals, arrhythmic burden, and time‑ and frequency‑domain HRV. Adjusted analyses used inverse‑probability weighting. Key exclusions were recent medication changes, cardiac implantable devices, chronic kidney disease, new cardiovascular disease, active infection, and shifts in physical activity. Results: Serum Mg increased in both supplementation arms; serum creatinine fell modestly, with no between‑group differences in change. Compared with combination and control, Mg‑oxide achieved greater reductions in 24‑hour systolic BP (mean Δ −4.2 mmHg; p=0.003) and 24‑hour diastolic BP (Δ −3.5 mmHg; p=0.003), plus a decrease in nighttime diastolic BP (Δ −4.4 mmHg; p=0.014). HR also declined with Mg‑oxide overnight (Δ −2.9 bpm; p=0.049) and over 24 hours (Δ −2.9 bpm; p=0.007), whereas changes with the combination or control were negligible. Time‑domain HRV improved with Mg‑oxide (RMSSD +22.2 ms, p=0.000; pNN50 +2.9%, p=0.006; NN50 +4.1×10³, p=0.032), with between‑group differences favouring Mg‑oxide for RMSSD, pNN50, and NN50 (all p
- 1 October 2025
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 16 (4) , 540-550
Nomogram-Based Evaluation of Exercise Capacity Based on Metabolic Equivalents (METs), Age, Body Mass Index(BMI), and Waist Circumference
Background/Purpose: Raw metabolic-equivalent (MET) cut-offs ignore how age and body size shape oxygen demand. The aim is derivation and validation of sex-specific nomograms that adjust treadmill MET performance for age, body-mass index (BMI) and waist circumference (WC). Methods: A prospective derivation cohort of 1 067 West-Eurasian adults who completed symptom-limited Bruce tests (January–December 2024) was analysed with multivariable linear regression (predictors: age, BMI, WC, sex). Internal validity used 1 000-fold bootstrap. External performance was assessed, without re-calibration, in an independent retrospective cohort of 900 tests from a separate laboratory. Results: Age, BMI and WC were independent determinants of absolute METs; smoking and resting heart rate were not. The model explained 24% of variance in women and 20% in men; optimism-corrected calibration was excellent (slope 0.99, intercept +0.08 METs). In the external cohort it retained good accuracy (R² = 0.32; SEE = 1.66 METs) and calibration (slope 1.06, intercept –0.84 METs). Compared with the age-only Gulati (women) and Morris (men) equations, the new model showed negligible bias (–0.12 ± 1.86 METs) and the lowest error (Brier 3.45 vs 11.21/9.68). Conclusions: Nomograms that integrate age, BMI and WC translate raw treadmill data into personalised, size-adjusted targets and flag values
- 1 October 2025
- Published by Acibadem Universitesi Saglik Bilimleri Dergisi in Acibadem Universitesi Saglik Bilimleri Dergisi
- Vol. 16 (4) , 540-550
Nomogram-Based Evaluation of Exercise Capacity Based on Metabolic Equivalents (METs), Age, Body Mass Index(BMI), and Waist Circumference
Background/Purpose: Raw metabolic-equivalent (MET) cut-offs ignore how age and body size shape oxygen demand. The aim is derivation and validation of sex-specific nomograms that adjust treadmill MET performance for age, body-mass index (BMI) and waist circumference (WC). Methods: A prospective derivation cohort of 1 067 West-Eurasian adults who completed symptom-limited Bruce tests (January–December 2024) was analysed with multivariable linear regression (predictors: age, BMI, WC, sex). Internal validity used 1 000-fold bootstrap. External performance was assessed, without re-calibration, in an independent retrospective cohort of 900 tests from a separate laboratory. Results: Age, BMI and WC were independent determinants of absolute METs; smoking and resting heart rate were not. The model explained 24% of variance in women and 20% in men; optimism-corrected calibration was excellent (slope 0.99, intercept +0.08 METs). In the external cohort it retained good accuracy (R² = 0.32; SEE = 1.66 METs) and calibration (slope 1.06, intercept –0.84 METs). Compared with the age-only Gulati (women) and Morris (men) equations, the new model showed negligible bias (–0.12 ± 1.86 METs) and the lowest error (Brier 3.45 vs 11.21/9.68). Conclusions: Nomograms that integrate age, BMI and WC translate raw treadmill data into personalised, size-adjusted targets and flag values
- 26 September 2025
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (2) , 92-96
Edge-to-edge transcatheter mitral repair for refractory heart failure: Case report and clinical insights
Secondary mitral regurgitation (SMR) aggravates prognosis in heart failure with reduced ejection fraction, particularly when guideline-directed medical therapy (GDMT) fails. Transcatheter edge-to-edge repair (TEER) has emerged as a viable option for high-risk surgical candidates. Herein, we report the case of a 77-year-old male with end-stage non-ischemic dilated cardiomyopathy and severe SMR who experienced five decompensations in three months despite optimal GDMT. This case illustrates that in select patients with advanced heart failure and severe SMR, TEER may provide meaningful symptomatic and hemodynamic improvement when surgical or mechanical circulatory support is not feasible. Key determinants of success included precise anatomic selection, preprocedural optimization with levosimendan and natriuresis-guided diuresis, and structured follow-up. TEER, when integrated into a multidisciplinary care pathway, offers more than palliation-it can help stabilize disease and preserve quality of life.
- 26 September 2025
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (2) , 92-96
Edge-to-edge transcatheter mitral repair for refractory heart failure: Case report and clinical insights
Secondary mitral regurgitation (SMR) aggravates prognosis in heart failure with reduced ejection fraction, particularly when guideline-directed medical therapy (GDMT) fails. Transcatheter edge-to-edge repair (TEER) has emerged as a viable option for high-risk surgical candidates. Herein, we report the case of a 77-year-old male with end-stage non-ischemic dilated cardiomyopathy and severe SMR who experienced five decompensations in three months despite optimal GDMT. This case illustrates that in select patients with advanced heart failure and severe SMR, TEER may provide meaningful symptomatic and hemodynamic improvement when surgical or mechanical circulatory support is not feasible. Key determinants of success included precise anatomic selection, preprocedural optimization with levosimendan and natriuresis-guided diuresis, and structured follow-up. TEER, when integrated into a multidisciplinary care pathway, offers more than palliation-it can help stabilize disease and preserve quality of life.
- 21 May 2025
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (1) , 31-34
Delayed recognition of myocardial infarction due to Herpes zoster and ventricular septal rupture as a complication: The impact of atypical presentations
Myocardial infarction is a leading cause of mortality worldwide, with chest pain being the hallmark symptom. However, atypical presentations can delay diagnosis and treatment, increasing the risk of complications. Herpes zoster, commonly known as shingles, typically presents with dermatomal pain, which can overlap with angina, leading to misdiagnosis. In this case report, a 67-year-old female with no prior comorbidities was diagnosed with Herpes zoster one week before presenting to the emergency department with persistent chest discomfort, weakness, and palpitations is presented.
- 21 May 2025
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 11 (1) , 31-34
Delayed recognition of myocardial infarction due to Herpes zoster and ventricular septal rupture as a complication: The impact of atypical presentations
Myocardial infarction is a leading cause of mortality worldwide, with chest pain being the hallmark symptom. However, atypical presentations can delay diagnosis and treatment, increasing the risk of complications. Herpes zoster, commonly known as shingles, typically presents with dermatomal pain, which can overlap with angina, leading to misdiagnosis. In this case report, a 67-year-old female with no prior comorbidities was diagnosed with Herpes zoster one week before presenting to the emergency department with persistent chest discomfort, weakness, and palpitations is presented.
- Open Access
- 13 May 2025
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 30, e948243
Post-Liver Transplantation Atrial Fibrillation: Insights into Clinical and ECG Predictors
BACKGROUND Liver transplant (LT) recipients have an increased risk for the development of postoperative atrial fibrillation (POAF). POAF has been associated with serious long-term outcomes such as thromboembolic events, stroke, heart failure, and even graft instability. MATERIAL AND METHODS We assessed potential clinical, biochemical, and ECG predictors of POAF in LT recipients between 2012 and 2024.The patients were divided into 2 groups: POAF and non-POAF (34.5%, n: 38 and 65.4, n: 72, respectively). RESULTS Basal characteristics and comorbidities of the 2 groups were similar. Patients in the POAF group had significantly higher heart rates (81.16±18.62 bpm vs 65.11±12.47 bpm, P<0.01) and longer maximal P-wave durations (169.47±20.41ms vs 145.06±33.99 ms, P<0.01). Maximal P-wave duration, PR interval, P-wave peak time in lead II (PWPT-II), QRS duration, and QTc interval were also significantly longer in the POAF group compared to the non-POAF group. With these consistent findings, we may consider that changes or abnormalities in P-wave indices are significant indicators of atrial conduction delay, even before the development of LA enlargement. CONCLUSIONS Our results are valuable in providing the prediction of POAF, which may be associated with major adverse outcomes such as mortality in LT recipients, using a simple and inexpensive tool like ECG. Such risks can be minimized by strategies such as optimization of beta-blocker therapy, fluid and electrolyte balance, and intraoperative temperature regulation.
- 13 May 2025
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 30, e948243
Open AccessPost-Liver Transplantation Atrial Fibrillation: Insights into Clinical and ECG Predictors
BACKGROUND Liver transplant (LT) recipients have an increased risk for the development of postoperative atrial fibrillation (POAF). POAF has been associated with serious long-term outcomes such as thromboembolic events, stroke, heart failure, and even graft instability. MATERIAL AND METHODS We assessed potential clinical, biochemical, and ECG predictors of POAF in LT recipients between 2012 and 2024.The patients were divided into 2 groups: POAF and non-POAF (34.5%, n: 38 and 65.4, n: 72, respectively). RESULTS Basal characteristics and comorbidities of the 2 groups were similar. Patients in the POAF group had significantly higher heart rates (81.16±18.62 bpm vs 65.11±12.47 bpm, P<0.01) and longer maximal P-wave durations (169.47±20.41ms vs 145.06±33.99 ms, P<0.01). Maximal P-wave duration, PR interval, P-wave peak time in lead II (PWPT-II), QRS duration, and QTc interval were also significantly longer in the POAF group compared to the non-POAF group. With these consistent findings, we may consider that changes or abnormalities in P-wave indices are significant indicators of atrial conduction delay, even before the development of LA enlargement. CONCLUSIONS Our results are valuable in providing the prediction of POAF, which may be associated with major adverse outcomes such as mortality in LT recipients, using a simple and inexpensive tool like ECG. Such risks can be minimized by strategies such as optimization of beta-blocker therapy, fluid and electrolyte balance, and intraoperative temperature regulation.
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (10) , 554-563
Women’s Representation in Interventional Cardiology and Other Interventional Fields: Opportunities and Challenges
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (10) , 554-563
Open AccessWomen’s Representation in Interventional Cardiology and Other Interventional Fields: Opportunities and Challenges
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- Open Access
- 1 April 2022
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 8 (1) , 26-29
Oral magnesium supplement induced acute retrosternal chest pain: An esophageal ulcer due to a less well-known cause
Retrosternal chest pain is the most common complaint of all emergency room visits. Once life-threatening causes have been thoroughly ruled out, other pathologies with favorable prognoses may be omitted. In this case report, we introduced a 79-year-old female patient with an esophageal ulcer who was complaining of severe acute onset retrosternal chest pain.
- 1 April 2022
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 8 (1) , 26-29
Open AccessOral magnesium supplement induced acute retrosternal chest pain: An esophageal ulcer due to a less well-known cause
Retrosternal chest pain is the most common complaint of all emergency room visits. Once life-threatening causes have been thoroughly ruled out, other pathologies with favorable prognoses may be omitted. In this case report, we introduced a 79-year-old female patient with an esophageal ulcer who was complaining of severe acute onset retrosternal chest pain.
- Open Access
- 1 December 2021
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 7 (3) , 276-279
Comparison of anxiety and depression scores between patients with and without ST-segment elevation acute coronary syndrome
Objectives: We aimed to investigate the difference between anxiety and depression status among ST-segment elevation acute coronary syndrome (STE-ACS) and non-ST-segment elevation ACS (NSTE-ACS) patients. Patients and methods: This study is a cross-sectional study that included 165 patients (132 males, 33 females; mean age: 59.3±10.5 years; range, 48 to 71 years) who were hospitalized with a final diagnosis of ACS (both NSTE-ACS and STE-ACS) between January 2019 and April 2019. The Hospital Anxiety and Depression Scale (HADS) was used to measure the patients' anxiety and depression status. Results: According to current European Society of Cardiology (ESC) guidelines, 91 (55.2%) patients were classified as NSTE-ACS and 74 (44.8%) patients as STE-ACS. According to the HADS scores, 33 (20%) of the total study population had anxiety diagnoses, and 28 (17%) of them had depression. While the mean depression score was 4.8±4.9 for NSTE-ACS patients, it was 4.6±4.3 for STE-ACS patients (p=0.723). The mean anxiety score was 6.1±5.1 for NSTE-ACS patients and 5.6±4.5 for STE-ACS patients (p=0.546), which was similar between the two groups. Conclusion: Although NSTE-ACS and STE-ACS are two different entities of ACS spectrum, patients hospitalized with these diagnoses have similar anxiety and depression scores.
- 1 December 2021
- Published by Baycinar Tibbi Yayincilik in Demiroglu Science University Florence Nightingale Journal of Medicine
- Vol. 7 (3) , 276-279
Open AccessComparison of anxiety and depression scores between patients with and without ST-segment elevation acute coronary syndrome
Objectives: We aimed to investigate the difference between anxiety and depression status among ST-segment elevation acute coronary syndrome (STE-ACS) and non-ST-segment elevation ACS (NSTE-ACS) patients. Patients and methods: This study is a cross-sectional study that included 165 patients (132 males, 33 females; mean age: 59.3±10.5 years; range, 48 to 71 years) who were hospitalized with a final diagnosis of ACS (both NSTE-ACS and STE-ACS) between January 2019 and April 2019. The Hospital Anxiety and Depression Scale (HADS) was used to measure the patients' anxiety and depression status. Results: According to current European Society of Cardiology (ESC) guidelines, 91 (55.2%) patients were classified as NSTE-ACS and 74 (44.8%) patients as STE-ACS. According to the HADS scores, 33 (20%) of the total study population had anxiety diagnoses, and 28 (17%) of them had depression. While the mean depression score was 4.8±4.9 for NSTE-ACS patients, it was 4.6±4.3 for STE-ACS patients (p=0.723). The mean anxiety score was 6.1±5.1 for NSTE-ACS patients and 5.6±4.5 for STE-ACS patients (p=0.546), which was similar between the two groups. Conclusion: Although NSTE-ACS and STE-ACS are two different entities of ACS spectrum, patients hospitalized with these diagnoses have similar anxiety and depression scores.